发明名称 Rapid Disperse Dosage Form Containing Levetiracetam
摘要 A high dose rapidly dispersing three-dimensionally printed dosage form comprising a high dose of levetiracetam in a porous matrix that disperses in water within a period of less than about 15 seconds is disclosed. Also disclosed are methods of preparing the dosage form and of treating a condition, disease or disorder that is therapeutically responsive to levetiracetam.
申请公布号 US2016220534(A1) 申请公布日期 2016.08.04
申请号 US201615095785 申请日期 2016.04.11
申请人 APRECIA PHARMACEUTICALS COMPANY 发明人 JACOB Jules;COYLE Norman;WEST Thomas G.;MONKHOUSE Donald C.;SURPRENANT Henry L.;JAIN Nemichand B.
分类号 A61K31/4015;A61K9/70;A61K9/00 主分类号 A61K31/4015
代理机构 代理人
主权项 1) A method of treating a disease, condition or disorder that is therapeutically responsive to levetiracetam comprising orally administering one or more times daily to a subject in need thereof a rapidly dispersible solid dosage form comprising levetiracetam in a bound porous matrix that disperses in about 15 sec or less in a volume of about 15 ml or less of water or saliva, wherein the dosage form provides a Cmax within the ranges listed below when respective doses of levetiracetam are administered to the subject in the fasting state:DoseCmax(mg)(micrograms/ml)100013-53750 9-37500 5-202504-7
地址 Langhorne PA US
您可能感兴趣的专利